C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 237/24 (2006.01) A61K 31/195 (2006.01) A61K 31/215 (2006.01) A61K 31/33 (2006.01) C07C 233/63 (2006.01) C07C 235/40 (2006.01) C07C 237/36 (2006.01) C07C 247/12 (2006.01) C07C 271/22 (2006.01) C07C 271/66 (2006.01) C07C 273/18 (2006.01) C07C 317/44 (2006.01) C07C 317/48 (2006.01) C07C 323/60 (2006.01) C07C 323/67 (2006.01) C07D 211/44 (2006.01) C07D 211/46 (2006.01) C07D 211/58 (2006.01) C07D 211/74 (2006.01) C07D 233/61 (2006.01) C07D 295/145 (2006.01) C07D 295/155 (2006.01) C07D 309/12 (2006.01) C07D
Patent
CA 2073450
2073450 9113054 PCTABS00007 Compounds of formula (I), wherein A completes a 5 or 6 membered carbocyclic ring which may be saturated or monounsaturated; Y is an alkylene group of from 1 to 9 carbon atoms; R1 is H or (C1-C4)alkyl; R and R4 are H, (C1-C6)alkyl, (C3-C7)cycloalkyl, benzyl, or an alternative biolabile ester-forming group; R2 is defined to include a range of substituent groups including (C1-C6)alkoxy, (C1-C4)alkoxy-(C1-C6)alkoxy and various substituted-alkyl, amino, substituted amino, aryl and heterocyclyl substituents linked directly or by O, S(O)n, NR6, CO or CONR6 wherein R6 is H, (C1-C4)alkyl or aryl(C1-C4)alkyl and n is 0, 1 or 2; R3 is a group of formula (II), wherein R13 is H, halo, 4-OH, 4-(C1-C6 alkoxy), 4-(C3-C7 cycloalkoxy), 4-(C2-C6 alkenyloxy), 4-[(C1-C6 alkoxy)carbonyloxy], 4-[(C3-C7 cycloalkyloxy)carbonyloxy], or 3-(C1-C4 alkyl)SO2NH-; and R14 is H, (C1-C4)alkyl, (C1-C4)alkoxy, (C2-C6)alkanoyl or halo; or R3 is a group of formulae (III) or (IV), wherein said groups may optionally be substituted in the fused benzene ring by (C1-C4)alkyl, (C1-C4)alkoxy, OH, halo or CF3; or are atriopeptidase inhibitors or utility in the treatment of hypertension and heart failure.
Brown David
Collis Alan J.
Danilewicz John C.
James Keith
Brown David
Collis Alan J.
Danilewicz John C.
James Keith
Limited Pfizer
LandOfFree
Cycloalkyl-substituted glutaramide antihypertensive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkyl-substituted glutaramide antihypertensive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl-substituted glutaramide antihypertensive agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1716152